Prescription Pricing for the People Act of 2023
Summary
Prescription Pricing for the People Act of 2023
This bill requires the Federal Trade Commission (FTC) to report about anticompetitive practices and other trends within the pharmaceutical supply chain that may impact the cost of prescription drugs. The FTC also must provide recommendations to increase transparency in the supply chain and prevent anticompetitive practices.
Lifecycle of the Bill
Introduced in Senate
Jan 16, 2025
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Jan 16, 2025